# Uro-1, Inc.

- Location (FDA's records): Winston Salem, NC
- FDA decisions: 3 (2018–2022): 3 510(k) clearances
- Product codes: KNW (2), FBK (1)
- Predicates its devices cite: 3 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Bard Peripheral Vascular, Inc.: 1 (https://510kreport.com/company/bard-peripheral-vascular)
- Riverpoint Medical: 1 (https://510kreport.com/company/riverpoint-medical)
- Laborie Medical Technologies, Ltd.: 1 (https://510kreport.com/company/laborie-medical-technologies)

## Firms that cite its devices most
- Carbon Medical Technologies, Inc.: 1 (https://510kreport.com/company/carbon-medical-technologies)

## Its most-cited devices
- K180214: Repris Bladder Injection System (2018), cited by 1

## Recent decisions
- K220611: SUREcore Plus Biopsy Instrument (Dec 2, 2022)
- K201650: VMCore Biopsy Needle (Jan 15, 2021)
- K180214: Repris Bladder Injection System (May 3, 2018)

Source page: https://510kreport.com/company/uro-1